Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |